Generic analytics tools often fail to address the complexity of patient data in pharma. Learn why putting specialized intelligence platforms in the hands of analytics as well as commercial teams is essential for generating actionable insights that drive better patient...

Bruce Goodwin, former President of Janssen Japan and Managing Director of Janssen ANZ as well as Prospection Board member, shares his reflections and key takeaways from moderating Prospection's Pharma Executive Roundtable on AI and Generative AI in Tokyo. Get Bruce's...

RWD alone isn't enough. To truly understand patients and drive meaningful improvements, you need PCI. Find out why RWD falls short and how PCI bridges the gap, providing pharmaceutical companies with the insights they need.

Mr. Eiichi Naka, a senior pharma leader with 40 years experience, discusses patient-centric PSPs and the impact of AI in driving outcomes in rare disease.

Prospection has won two prestigious awards from APAC Insider. These achievements reflect our dedication to improving healthcare through cutting-edge technology.

Discover how AI and patient-centric intelligence are transforming pharma's approach to commercial strategy. Ipsen's Nicholas Phillips shares insights on leveraging AI for data-driven decision-making and improved patient outcomes.

Successful brand planning is the product of great synergy between analytics and commercial teams. Patient-centric intelligence (PCI) has emerged as a game-changer, bridging the gap between these teams and enabling data-driven decision-making. Discover how PCI can enhance collaboration, improve brand...

Discover the power of patient-centric intelligence in our latest whitepaper, "Connect Care at the Core: A Brand Planning Guide." This comprehensive resource explores how leveraging real-world insights can transform your brand planning process, uplifting market share and patient care.

Eric Chung, co-founder of Prospection, shares his experience on how patient-centric intelligence (PCI) can transform pharmaceutical launches. Learn how leveraging vast patient data and advanced techniques like machine learning can produce intelligence that optimises launch strategies, improves resource allocation, and...

A recent study in eJHaem led by Anoop Enjeti, MD, PhD, in collaboration with Otsuka and Prospection, highlights the importance of treatment adherence and the need for more treatment options for Myelodysplastic Syndromes (MDS). It also showcases the critical role...

A recent study by Johnson & Johnson Innovative Medicine Asia Pacific, in collaboration with Prospection, utilised patient-centric intelligence (PCI) in Japan to evaluate the persistence of endothelin receptor antagonists in pulmonary arterial hypertension (PAH) treatment.

Patient-centric Intelligence (PCI) is transforming the way pharmas manage their brands. It helps companies quickly get to actionable insights informed by the patient journey, and insights centered around patients inevitably lead to better outcomes, for pharmas as well as patients.